Aethlon Medical Inc (AEMD)

[djpope]

Just shows how delusional both you & your SH buddy are. Reverse split 4 years ago you say? Less than a year and a half is more like it.

And, as you say, "all the years that I've been sitting on the board" LOL. I sit in a chair like normal people do and visit the board when it shows posts have been made or when something notable to post about or refute comes up like your or SH's erroneous statements.

I've been here since 10/29/2014 (#7717) for a total of 283 posts as opposed to you that has been here a little bit shorter time from 11/13/2014 (#8335) but you have more than double the posts at 664 total. So if anyone is doing any "board sitting" and fabricating... It's you.

Both you and the SH are destroyers into demolition and tearing things with Aethlon down for Whatever? reasons that you have. I hope that both of you have shorted the stock, then your posts make sense and will Hopefully eventually lose you dollars. If not short, can't either of you find anything more constructive to do with your time or find something you can support other than being so destructive and enjoyably defeatist. Such a negative way to live and something that will only come back to bite you at some time in your life. Maybe try taking up knitting, needlepoint or crocheting. I hear it's quite calming and relaxing and Helps keep your mind off the monsters that lurk there...

Well, you must Enjoy bathing in the negative crap since you both slather yourselves with it all the time. Thankfully, I don't get my rocks off on that kind of stuff and always prefer to be positive. If I don't like the show or the book I don't rant and rave how bad it is, I just put it down or leave. Maybe both of you should think about doing the same.

Proverbs 12:13
An evil man is ensnared by the transgression of his lips, But the righteous will escape from trouble.

Enjoy! dp

Apr 14, 2015 - Aethlon Medical Announces Effectiveness of Reverse Stock Split

Aethlon Medical, Inc. (OTCQB:AEMD), a pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, announced today that its previously disclosed 1-for-50 reverse...